HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The pharmacokinetics and pharmacodynamics of prophylactic doses of aspirin in pregnant women from a group at risk for placental insufficiency].

Abstract
The pharmacokinetics and pharmacodynamics of small-dose aspirin (60 mg/day) were studied during the second to the third trimesters in pregnant females at a high risk of placental insufficiency. In the group of pregnant women with uncomplicated pregnancies (n = 16), the aspirin kinetic changes which presented with a lower concentration-time index, higher total clearance and larger distribution volume were associated with the gestational age. Similar changes were revealed in the group of pregnant women (n = 4) with advanced placental insufficiency. The findings suggest that the optimal therapeutical aspirin doses should be chosen by the gestational age rather than by the severity of placental insufficiency.
AuthorsG U Asymbekova, P D Banartsev, T B Ochan, B E Rozenfel'd, A K Sariev, I Iu Folomeeva, S V Pavlovich
JournalEksperimental'naia i klinicheskaia farmakologiia (Eksp Klin Farmakol) 1995 Mar-Apr Vol. 58 Issue 2 Pg. 35-9 ISSN: 0869-2092 [Print] Russia (Federation)
Vernacular TitleFarmakokinetika i farmakodinamika profilakticheskikh doz aspirina u beremennykh gruppy riska po platsentarnoĭ nedostatochnosti.
PMID7773087 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aspirin
Topics
  • Adult
  • Aspirin (administration & dosage, pharmacokinetics, pharmacology)
  • Blood Platelets (drug effects, ultrastructure)
  • Blood Viscosity (drug effects)
  • Drug Evaluation
  • Female
  • Humans
  • Placental Insufficiency (blood, diagnostic imaging, prevention & control)
  • Pregnancy
  • Pregnancy Trimester, Second
  • Pregnancy Trimester, Third
  • Risk Factors
  • Time Factors
  • Ultrasonography, Prenatal

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: